LOC644584: A Potential Drug Target and Biomarker for Ewing Sarcoma

LOC644584: A Potential Drug Target and Biomarker for Ewing Sarcoma

LOC644584 is a protein that is found in Ewing sarcoma, a type of cancer that affects the bones and other parts of the body. The protein is located in the breakpoint region 1 of the Ewing sarcoma gene and is known for its unique structure and function.

Recent studies have suggested that LOC644584 may be a drug target or biomarker for the treatment of Ewing sarcoma. This is because the protein has been shown to be expressed in high levels in the tissues of people with Ewing sarcoma, and because it has been shown to interact with several drugs that are currently being used to treat the disease.

One of the reasons why LOC644584 may be a drug target is because it has been shown to play a role in the development and progression of Ewing sarcoma. Studies have shown that people with Ewing sarcoma are more likely to have high levels of LOC644584 in their tissues, and that this is associated with a poor prognosis. Additionally, several studies have shown that LOC644584 is expressed in the majority of Ewing sarcoma tumors, and that inhibiting its activity may be a effective way to treat the disease.

Another potential reason why LOC644584 may be a drug target is because it has been shown to interact with several drugs that are currently being used to treat Ewing sarcoma. For example, studies have shown that the drug tamoxifen can inhibit the activity of LOC644584 and may be a useful treatment for people with the disease. Additionally, several other drugs that are commonly used to treat breast and ovarian cancer have also been shown to interact with LOC644584, suggesting that they may be effective treatments for Ewing sarcoma as well.

In addition to its potential as a drug target, LOC644584 may also be a biomarker for the diagnosis and prognosis of Ewing sarcoma. Studies have shown that LOC644584 is expressed in the majority of Ewing sarcoma tumors, and that its levels are often higher in these tumors compared to other types of cancer. This suggests that LOC644584 may be a useful biomarker for the diagnosis and prognosis of Ewing sarcoma.

Overall, LOC644584 is a protein that has been shown to play a role in the development and progression of Ewing sarcoma. Its levels are often higher in people with this type of cancer, and it has been shown to interact with several drugs that are currently being used to treat the disease. Further research is needed to fully understand the role of LOC644584 in Ewing sarcoma and to determine its potential as a drug target or biomarker.

Protein Name: EWS RNA Binding Protein 1 Pseudogene

The "LOC644584 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC644584 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC644634 | LOC644656 | LOC644662 | LOC644669 | LOC644893 | LOC644936 | LOC645086 | LOC645181 | LOC645188 | LOC645266 | LOC645468 | LOC645503 | LOC645967 | LOC646044 | LOC646214 | LOC646358 | LOC646471 | LOC646674 | LOC646736 | LOC646762 | LOC646813 | LOC646836 | LOC646853 | LOC646903 | LOC646934 | LOC646970 | LOC647115 | LOC647132 | LOC647481 | LOC649133 | LOC650157 | LOC650226 | LOC651536 | LOC652276 | LOC652608 | LOC653303 | LOC653503 | LOC653513 | LOC653631 | LOC653653 | LOC653698 | LOC727751 | LOC728024 | LOC728098 | LOC728114 | LOC728138 | LOC728376 | LOC728392 | LOC728417 | LOC728485 | LOC728554 | LOC728660 | LOC728688 | LOC728715 | LOC728739 | LOC728743 | LOC728877 | LOC728989 | LOC729086 | LOC729164 | LOC729173 | LOC729218 | LOC729296 | LOC729444 | LOC729609 | LOC729683 | LOC729732 | LOC729737 | LOC729815 | LOC729870 | LOC729887 | LOC729966 | LOC729973 | LOC730098 | LOC730100 | LOC730101 | LOC730183 | LOC730234 | LOC730338 | LOC730668 | LOC90246 | LOC91450 | LOC93429 | LOC93463 | LOC93622 | LOH12CR2 | Long intergenic non-protein coding RNA 1336 | Long intergenic non-protein coding RNA 205 | Long intergenic non-protein coding RNA 266-4, pseudogene | Long-chain-fatty-acid--CoA ligase | LONP1 | LONP2 | LONRF1 | LONRF2 | LONRF3 | LORICRIN | LOX | LOXHD1 | LOXL1 | LOXL1-AS1